HEADER HYDROLASE/HYDROLASE SUBSTRATE 13-NOV-99 1DE7 TITLE INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: TITLE 2 CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-THROMBIN (LIGHT CHAIN); COMPND 3 CHAIN: L, J; COMPND 4 EC: 3.4.21.5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ALPHA-THROMBIN (HEAVY CHAIN); COMPND 7 CHAIN: H, K; COMPND 8 EC: 3.4.21.5; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: FACTOR XIII ACTIVATION PEPTIDE (28-37); COMPND 11 CHAIN: A, B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: PLASMA; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: PLASMA; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES KEYWDS ENZYME-SUBSTRATE COMPLEX, ALPHA-THROMBIN, FACTOR XIII ACTIVATION KEYWDS 2 PEPTIDE, HYDROLASE/PEPTIDE, BLOOD CLOTTING, HYDROLASE-HYDROLASE KEYWDS 3 SUBSTRATE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.SADASIVAN,V.C.YEE REVDAT 4 09-AUG-23 1DE7 1 REMARK LINK REVDAT 3 13-JUL-11 1DE7 1 VERSN REVDAT 2 24-FEB-09 1DE7 1 VERSN REVDAT 1 13-DEC-00 1DE7 0 JRNL AUTH C.SADASIVAN,V.C.YEE JRNL TITL INTERACTION OF THE FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA JRNL TITL 2 -THROMBIN. CRYSTAL STRUCTURE OF ITS ENZYME-SUBSTRATE ANALOG JRNL TITL 3 COMPLEX. JRNL REF J.BIOL.CHEM. V. 275 36942 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10956659 JRNL DOI 10.1074/JBC.M006076200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.BODE,D.TURK,A.KARSHIKOV REMARK 1 TITL THE REFINED 1.9 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF REMARK 1 TITL 2 D-PHE-PRO-ARG CHLOROMETHYLKETONE-INHIBITED HUMAN REMARK 1 TITL 3 ALPHA-THROMBIN: STRUCTURE ANALYSIS, OVERALL STRUCTURE, REMARK 1 TITL 4 ELECTROSTATIC PROPERTIES, DETAILED ACTIVE-SITE GEOMETRY, AND REMARK 1 TITL 5 STRUCTURE-FUNCTION RELATIONSHIPS REMARK 1 REF PROTEIN SCI. V. 1 426 1992 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.T.STUBBS,H.OSCHKINAT,I.MAYER,R.HUBER,H.ANGLIKER, REMARK 1 AUTH 2 S.R.STONER,W.BODE REMARK 1 TITL THE INTERACTION OF THROMBIN WITH FIBRINOGEN: A STRUCTURAL REMARK 1 TITL 2 BASIS FOR ITS SPECIFICITY REMARK 1 REF EUR.J.BIOCHEM. V. 206 187 1992 REMARK 1 REFN ISSN 0014-2956 REMARK 1 REFERENCE 3 REMARK 1 AUTH V.C.YEE,L.C.PEDERSEN,I.L.TRONG,P.D.BISHOP,R.E.STENKAMP, REMARK 1 AUTH 2 D.C.TELLER REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN REMARK 1 TITL 2 BLOOD COAGULATION FACTOR XIII REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 91 7296 1994 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 44341 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2226 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4466 REMARK 3 BIN R VALUE (WORKING SET) : 0.2718 REMARK 3 BIN FREE R VALUE : 0.3069 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4633 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 479 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 2.460 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAM19.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPH19.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DE7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-99. REMARK 100 THE DEPOSITION ID IS D_1000010012. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 93.0 REMARK 200 PH : 5.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : YALE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45245 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.15700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: THROMBIN CRYSTAL STRUCTURE WITH PDB ID 1AHT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, SODIUM CHLORIDE, SODIUM REMARK 280 CITRATE, PH 5.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.63000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE TWO INDEPENDENT COMPLEXES IN THE ASYMMETRIC REMARK 300 UNIT: REMARK 300 REMARK 300 COMPLEX 1 REMARK 300 ALPHA-THROMBIN: CHAINS L, H REMARK 300 FACTOR XIII PEPTIDE: CHAIN A REMARK 300 REMARK 300 COMPLEX 2 REMARK 300 ALPHA-THROMBIN: CHAINS J, K REMARK 300 FACTOR XIII PEPTIDE: CHAIN B REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE FACTOR XIII DERIVED PEPTIDE CONTAIN A C-TERMINAL REMARK 400 CHLOROMETHYLKETONE GROUP AND IS COVALENTLY CONNECTED TO ACTIVE_SITE REMARK 400 RESIDUES OF THROMBIN. THE UNBOUND FORM OF THE PEPTIDE IS THR-VAL- REMARK 400 GLU-LEU-GLN-GLY-VAL-VAL-PRO-ARG-CHLOROMETHYLKETONE. UPON REACTION REMARK 400 WITH PROTEIN IT FORMS TWO COVALENT BONDS: 1) VIA A HEMIKETAL GROUP REMARK 400 TO OG SER H 195; 2) VIA A METHYLENE GROUP TO NE2 HIS H 57. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR L -4 REMARK 465 PHE L -3 REMARK 465 GLY L -2 REMARK 465 SER L -1 REMARK 465 GLY L 0 REMARK 465 ASP L 15 REMARK 465 GLY L 16 REMARK 465 ARG L 17 REMARK 465 TRP H 147A REMARK 465 THR H 147B REMARK 465 ALA H 147C REMARK 465 ASN H 147D REMARK 465 VAL H 147E REMARK 465 GLY H 147F REMARK 465 LYS H 147G REMARK 465 PHE H 245 REMARK 465 GLY H 246 REMARK 465 GLU H 247 REMARK 465 THR J -6 REMARK 465 PHE J -5 REMARK 465 GLY J -4 REMARK 465 SER J -3 REMARK 465 GLY J -2 REMARK 465 GLU J -1 REMARK 465 ALA J 0 REMARK 465 ASP J 15 REMARK 465 GLY J 16 REMARK 465 ARG J 17 REMARK 465 TRP K 147A REMARK 465 THR K 147B REMARK 465 ALA K 147C REMARK 465 ASN K 147D REMARK 465 VAL K 147E REMARK 465 GLY K 147F REMARK 465 LYS K 147G REMARK 465 GLU K 247 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN K 244 CB CG CD OE1 NE2 REMARK 470 PHE K 245 CB CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER K 195 C AR7 B 37 1.39 REMARK 500 OG SER H 195 C AR7 A 37 1.39 REMARK 500 C AR7 A 37 C1 0QE A 38 1.53 REMARK 500 C AR7 B 37 C1 0QE B 38 1.54 REMARK 500 OG SER K 195 O AR7 B 37 2.00 REMARK 500 OG SER H 195 C1 0QE A 38 2.15 REMARK 500 OG SER H 195 O AR7 A 37 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS H 57 NE2 HIS H 57 CD2 -0.073 REMARK 500 HIS H 71 NE2 HIS H 71 CD2 -0.069 REMARK 500 HIS H 119 NE2 HIS H 119 CD2 -0.068 REMARK 500 HIS H 230 NE2 HIS H 230 CD2 -0.072 REMARK 500 HIS K 57 NE2 HIS K 57 CD2 -0.072 REMARK 500 HIS K 71 NE2 HIS K 71 CD2 -0.068 REMARK 500 HIS K 91 NE2 HIS K 91 CD2 -0.067 REMARK 500 HIS K 119 NE2 HIS K 119 CD2 -0.071 REMARK 500 HIS K 230 NE2 HIS K 230 CD2 -0.071 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP H 29 CD1 - CG - CD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 TRP H 29 CE2 - CD2 - CG ANGL. DEV. = -5.5 DEGREES REMARK 500 TRP H 51 CD1 - CG - CD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 TRP H 51 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP H 51 CG - CD2 - CE3 ANGL. DEV. = 5.4 DEGREES REMARK 500 TRP H 60D CD1 - CG - CD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TRP H 60D CE2 - CD2 - CG ANGL. DEV. = -5.7 DEGREES REMARK 500 TRP H 96 CD1 - CG - CD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 TRP H 96 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP H 141 CD1 - CG - CD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TRP H 141 CE2 - CD2 - CG ANGL. DEV. = -5.5 DEGREES REMARK 500 CYS H 182 CA - CB - SG ANGL. DEV. = 7.5 DEGREES REMARK 500 TRP H 207 CD1 - CG - CD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 TRP H 207 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 TRP H 215 CD1 - CG - CD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 TRP H 215 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TRP H 237 CD1 - CG - CD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 TRP H 237 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 TRP K 29 CD1 - CG - CD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 TRP K 29 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TRP K 51 CD1 - CG - CD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 TRP K 51 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TRP K 60D CD1 - CG - CD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TRP K 60D CE2 - CD2 - CG ANGL. DEV. = -5.6 DEGREES REMARK 500 TRP K 96 CD1 - CG - CD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 TRP K 96 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 TRP K 141 CD1 - CG - CD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 TRP K 141 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 CYS K 182 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 TRP K 207 CD1 - CG - CD2 ANGL. DEV. = 5.3 DEGREES REMARK 500 TRP K 207 CE2 - CD2 - CG ANGL. DEV. = -5.7 DEGREES REMARK 500 TRP K 215 CD1 - CG - CD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 TRP K 215 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 TRP K 237 CD1 - CG - CD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 TRP K 237 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE L 7 -77.83 -126.44 REMARK 500 ASP H 60E 15.99 59.26 REMARK 500 ASN H 60G 78.28 -159.82 REMARK 500 ASN H 95 76.80 -117.65 REMARK 500 SER H 214 -56.34 -129.16 REMARK 500 PHE J 7 -81.38 -127.64 REMARK 500 GLN K 38 97.96 -59.31 REMARK 500 ASN K 60G 109.00 -166.36 REMARK 500 HIS K 71 -57.86 -122.61 REMARK 500 ASN K 78 -6.00 72.94 REMARK 500 ILE K 79 -66.28 -93.01 REMARK 500 CYS K 191 -153.12 -142.55 REMARK 500 SER K 214 -58.74 -129.45 REMARK 500 PHE K 245 84.76 66.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR H 225 0.11 SIDE CHAIN REMARK 500 TYR K 225 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA H 1 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG H 221A O REMARK 620 2 LYS H 224 O 95.5 REMARK 620 3 HOH H 249 O 161.3 69.9 REMARK 620 4 HOH H 250 O 101.4 163.0 93.9 REMARK 620 5 HOH H 251 O 95.7 77.8 92.6 98.5 REMARK 620 6 HOH H 252 O 91.2 97.6 79.7 83.9 172.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA K 2 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG K 221A O REMARK 620 2 LYS K 224 O 87.4 REMARK 620 3 HOH K 249 O 155.0 71.7 REMARK 620 4 HOH K 250 O 105.9 165.7 96.5 REMARK 620 5 HOH K 251 O 86.7 100.8 84.2 85.6 REMARK 620 6 HOH K 252 O 95.9 68.8 89.2 103.8 169.1 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA H 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA K 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF FACTOR XIII REMARK 800 ACTIVATION PEPTIDE (28-37) REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF FACTOR XIII REMARK 800 ACTIVATION PEPTIDE (28-37) REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHYMOTRYPSINOGEN NUMBERING (RATHER THAN SEQUENTIAL) SYSTEM REMARK 999 IS USED FOR THROMBIN, BASED ON THE TOPOLOGICAL ALIGNMENT REMARK 999 WITH THE STRUCTURE OF CHYMOTRYPSINOGEN (W.BODE ET AL., 1989, REMARK 999 EMBO J. 4 8, 3467-3475). REMARK 999 PEPTIDE NUMBERING IS BASED ON THE CORRESPONDING RESIDUES REMARK 999 IN FACTOR XIII DBREF 1DE7 L 1A 14K UNP P00734 THRB_HUMAN 328 363 DBREF 1DE7 H 16 244 UNP P00734 THRB_HUMAN 364 622 DBREF 1DE7 J 1A 14K UNP P00734 THRB_HUMAN 328 363 DBREF 1DE7 K 16 244 UNP P00734 THRB_HUMAN 364 622 DBREF 1DE7 A 28 38 PDB 1DE7 1DE7 28 38 DBREF 1DE7 B 28 38 PDB 1DE7 1DE7 28 38 SEQRES 1 L 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 L 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 L 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 J 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 J 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 J 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 K 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 K 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 K 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 K 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 K 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 K 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 K 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 K 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 K 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 K 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 K 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 K 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 K 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 K 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 K 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 K 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 K 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 K 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 K 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 K 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 A 11 THR VAL GLU LEU GLN GLY VAL VAL PRO AR7 0QE SEQRES 1 B 11 THR VAL GLU LEU GLN GLY VAL VAL PRO AR7 0QE MODRES 1DE7 AR7 A 37 ARG MODRES 1DE7 AR7 B 37 ARG HET AR7 A 37 11 HET 0QE A 38 1 HET AR7 B 37 11 HET 0QE B 38 1 HET NA H 1 1 HET NA K 2 1 HETNAM AR7 AMINO{[(4S)-4-AMINO-5,5- HETNAM 2 AR7 DIHYDROXYPENTYL]AMINO}METHANIMINIUM HETNAM 0QE CHLOROMETHANE HETNAM NA SODIUM ION HETSYN 0QE CHLORO METHYL GROUP FORMUL 5 AR7 2(C6 H17 N4 O2 1+) FORMUL 5 0QE 2(C H3 CL) FORMUL 7 NA 2(NA 1+) FORMUL 9 HOH *479(H2 O) HELIX 1 1 PHE L 7 SER L 11 5 5 HELIX 2 3 ALA H 55 CYS H 58 5 4 HELIX 3 6 ASP H 125 LEU H 130 1 9 HELIX 4 7 GLU H 164 THR H 172 1 9 HELIX 5 8 LEU H 234 GLN H 244 1 11 HELIX 6 9 PHE J 7 SER J 11 5 5 HELIX 7 11 ALA K 55 CYS K 58 5 4 HELIX 8 13 ASP K 125 LEU K 130 1 9 HELIX 9 14 GLU K 164 SER K 171 1 8 HELIX 10 15 LEU K 234 GLN K 244 1 11 HELIX 11 16 THR A 28 GLY A 33 5 6 SHEET 1 A 4 LYS H 81 MET H 84 0 SHEET 2 A 4 LEU H 64 ILE H 68 -1 N ILE H 68 O LYS H 81 SHEET 3 A 4 GLN H 30 ARG H 35 -1 N PHE H 34 O LEU H 65 SHEET 4 A 4 GLU H 39 SER H 45 -1 N ALA H 44 O VAL H 31 SHEET 1 B 3 TRP H 51 THR H 54 0 SHEET 2 B 3 ALA H 104 LEU H 108 -1 N MET H 106 O VAL H 17 SHEET 3 B 3 LEU H 59 ILE H 90 -1 N TYR H 89 O LEU H 105 SHEET 1 C 2 LYS H 135 GLY H 140 0 SHEET 2 C 2 GLN H 156 PRO H 161 -1 N LEU H 160 O GLY H 136 SHEET 1 D 4 MET H 180 ALA H 183 0 SHEET 2 D 4 GLY H 226 HIS H 230 -1 N TYR H 228 O PHE H 181 SHEET 3 D 4 TRP H 207 TRP H 215 -1 N TRP H 215 O PHE H 227 SHEET 4 D 4 PRO H 198 LYS H 202 -1 N MET H 201 O TYR H 208 SHEET 1 E 4 LYS K 81 MET K 84 0 SHEET 2 E 4 LEU K 64 ILE K 68 -1 N ILE K 68 O LYS K 81 SHEET 3 E 4 GLN K 30 ARG K 35 -1 N PHE K 34 O LEU K 65 SHEET 4 E 4 GLU K 39 SER K 45 -1 N ALA K 44 O VAL K 31 SHEET 1 F 3 TRP K 51 THR K 54 0 SHEET 2 F 3 ALA K 104 LEU K 108 -1 N MET K 106 O VAL K 52 SHEET 3 F 3 LEU K 85 ILE K 90 -1 N TYR K 89 O LEU K 105 SHEET 1 G 2 LYS K 135 GLY K 140 0 SHEET 2 G 2 GLN K 156 PRO K 161 -1 N LEU K 160 O GLY K 136 SHEET 1 H 4 MET K 180 ALA K 183 0 SHEET 2 H 4 GLY K 226 HIS K 230 -1 N TYR K 228 O PHE K 181 SHEET 3 H 4 TRP K 207 TRP K 215 -1 N TRP K 215 O PHE K 227 SHEET 4 H 4 PRO K 198 LYS K 202 -1 N MET K 201 O TYR K 208 SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.01 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.02 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.01 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.03 SSBOND 5 CYS J 1 CYS K 122 1555 1555 2.02 SSBOND 6 CYS K 42 CYS K 58 1555 1555 2.02 SSBOND 7 CYS K 168 CYS K 182 1555 1555 2.02 SSBOND 8 CYS K 191 CYS K 220 1555 1555 2.02 LINK NE2 HIS H 57 C1 0QE A 38 1555 1555 1.45 LINK NE2 HIS K 57 C1 0QE B 38 1555 1555 1.46 LINK NA NA H 1 O ARG H 221A 1555 1555 2.22 LINK NA NA H 1 O LYS H 224 1555 1555 2.18 LINK NA NA H 1 O HOH H 249 1555 1555 2.19 LINK NA NA H 1 O HOH H 250 1555 1555 2.16 LINK NA NA H 1 O HOH H 251 1555 1555 2.20 LINK NA NA H 1 O HOH H 252 1555 1555 2.22 LINK NA NA K 2 O ARG K 221A 1555 1555 2.18 LINK NA NA K 2 O LYS K 224 1555 1555 2.16 LINK NA NA K 2 O HOH K 249 1555 1555 2.18 LINK NA NA K 2 O HOH K 250 1555 1555 2.16 LINK NA NA K 2 O HOH K 251 1555 1555 2.24 LINK NA NA K 2 O HOH K 252 1555 1555 2.16 CISPEP 1 SER H 36A PRO H 37 0 -6.84 CISPEP 2 SER K 36A PRO K 37 0 -1.89 CISPEP 3 PHE K 245 GLY K 246 0 0.32 SITE 1 CAT 6 HIS H 57 ASP H 102 SER H 195 HIS K 57 SITE 2 CAT 6 ASP K 102 SER K 195 SITE 1 AC1 6 ARG H 221A LYS H 224 HOH H 249 HOH H 250 SITE 2 AC1 6 HOH H 251 HOH H 252 SITE 1 AC2 6 ARG K 221A LYS K 224 HOH K 249 HOH K 250 SITE 2 AC2 6 HOH K 251 HOH K 252 SITE 1 AC3 26 HOH A 114 HOH A 118 HOH A 150 HOH A 193 SITE 2 AC3 26 HOH A 255 HOH A 275 HOH A 415 HIS H 57 SITE 3 AC3 26 TYR H 60A ARG H 97 GLU H 97A ILE H 174 SITE 4 AC3 26 ASP H 189 ALA H 190 GLY H 193 SER H 195 SITE 5 AC3 26 SER H 214 TRP H 215 GLY H 216 GLU H 217 SITE 6 AC3 26 GLY H 219 GLY H 226 HOH H 290 HOH H 291 SITE 7 AC3 26 HOH H 294 HOH H 331 SITE 1 AC4 22 HOH B 376 HIS K 57 TYR K 60A TRP K 60D SITE 2 AC4 22 ARG K 97 GLU K 97A ARG K 173 ILE K 174 SITE 3 AC4 22 ASP K 189 ALA K 190 CYS K 191 GLU K 192 SITE 4 AC4 22 GLY K 193 SER K 195 SER K 214 TRP K 215 SITE 5 AC4 22 GLY K 216 GLU K 217 GLY K 219 GLY K 226 SITE 6 AC4 22 HOH K 253 HOH K 348 CRYST1 54.070 81.260 85.460 90.00 101.62 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018495 0.000000 0.003803 0.00000 SCALE2 0.000000 0.012306 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011946 0.00000